We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

MEDMIRA

MedMira Inc. is a biotechnology company that researches, develops, manufactures, and commercializes rapid diagnostics... read more Featured Products: More products

Download Mobile App




Unique Quantitative Diagnostic System Enables Immediate Diagnosis and Treatment at POC

By LabMedica International staff writers
Posted on 01 Apr 2024
Print article
Image: MedMira has received a Canadian patent for its unique quantitative diagnostic system (Photo courtesy of MedMira)
Image: MedMira has received a Canadian patent for its unique quantitative diagnostic system (Photo courtesy of MedMira)

The use of rapid diagnostic tests has markedly expanded in recent years, primarily serving as an initial step by offering qualitative results. Now, a unique diagnostic system that offers both qualitative and quantitative results could allow healthcare providers to receive an immediate diagnosis, making it a truly point-of-care solution for the on-the-spot treatment of patients.

MedMira Inc.’s (Halifax, NS, Canada) rapid multiplexed quantitative diagnostic system offers a total solution from screening to confirmation to monitoring disease progression. The novel diagnostic system allows for accessible and efficient diagnostic tools for quantitative results in minutes. Its user-friendly interface combined with automated interpretation allows for the expansion of MedMira's current Rapid Vertical Flow Technology (RVF) based diagnostic tests and can provide a pathway to significantly increase the technology's multiplexing abilities. The combination of the RVF and Surface-Enhanced Raman Spectroscopy (SERS) technology creates MedMira's novel high-quality and cost-effective tool for the next generation - MIROQ.

MIROQ significantly amplifies the results of MedMira’s RVF-based rapid tests by generating a distinctive 3D structure with remarkable reproducibility that is yielded in a linear plot (R2 = 0.98). This will allow MedMira to expand its access in both the clinical immunoassay and the Point-of-Care markets, opening new doors into the evolving diagnostic landscape by providing both qualitative and quantitative test results in minutes. The synergies between both the technologies allow MedMira to provide a highly effective and affordable alternative to the current costly and time-consuming screening and monitoring systems. MedMira has received a Canadian patent for its new innovative and quantitative test system, in addition to the U.S. patent received in 2022.

"All our rapid tests are based on MedMira's patented RVF Technology and provide an immediate quality Yes or No answer(s). Our speed in addition to our unique control line, allow for the fastest and high-quality answer(s) at a real Point-of-Care setting. While the use of rapid tests has significantly increased over the last years, rapid tests are the first step by providing qualitative result(s). MedMira's vision is to expand this further by adding a unique value to its MIROQ system. The Company's RVF Technology together with the MIROQ technology allows health care providers to receive an immediate diagnosis with both qualitative AND quantitative results." said Hermes Chan, CEO of MedMira Inc. "The synergies of both systems provide the highest quality answers within in minutes and at the most economical costs for health care providers. This combination allows for a truly Point-of-Care situation and enables for immediate treatment of patients. Our future vision has already become reality with MIROQ."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.